MBX
MBX Biosciences Inc.
$21.03
+$0.42(+2.04%)
65
Overall
--
Value
91
Tech
39
Quality
Market Cap
$335.94M
Volume
421.38K
52W Range
$4.81 - $27.50
Target Price
$59.00
Order:
Income Statement
| Metric | Trend | Chart | 2023 Dec | 2024 Dec |
|---|---|---|---|---|
| OPERATING EXPENSES | ||||
| Operating Expenses | $35.3M | $68.2M | ||
| Research & Development | $28.5M | $57.4M | ||
| Research Expense | $28.5M | $57.4M | ||
| Selling, General & Administrative | $6.8M | $10.8M | ||
| General & Administrative Expenses | $6.8M | $10.8M | ||
| Depreciation & Amortization | -- | $200.0K | ||
| Depreciation & Amortization | -- | $200.0K | ||
| Other Operating Expenses | -- | $-2.1M | ||
| OPERATING INCOME | ||||
| Operating income | $-35.3M | $-68.2M | ||
| EBITDA | $-32.4M | $-61.7M | ||
| NON-OPERATING ITEMS | ||||
| Intinc | $2.7M | $6.3M | ||
| Net Non-Operating Interest Income/Expense | $2.7M | $6.3M | ||
| PRE-TAX INCOME | ||||
| EBIT | $-32.6M | $-61.9M | ||
| Pre-Tax Income | $-32.6M | $-61.9M | ||
| NET INCOME | ||||
| Net Income | $-32.6M | $-61.9M | ||
| Net Income (Continuing Operations) | $-32.6M | $-61.9M | ||
| Net Income (Discontinued Operations) | $-32.6M | $-61.9M | ||
| Net Income (Common Stockholders) | $-32.6M | $-61.9M | ||
| Normalized Income | $-23.9M | $-61.3M | ||
| TOTALS | ||||
| Total Expenses | $35.3M | $68.2M | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $1.0M | $10.6M | ||
| Average Shares Outstanding (Diluted) | $1.0M | $10.6M | ||
| Shares Outstanding | $33.6M | $33.4M | ||
| Basic EPS | $-31.96 | $-5.82 | ||
| Basic EPS (Continuing Operations) | $-31.96 | $-5.82 | ||
| Diluted EPS | $-31.96 | $-5.82 | ||
| Diluted EPS (Continuing Operations) | $-31.96 | $-5.82 | ||
| OTHER METRICS | ||||
| Other Gand A | $6.8M | $10.8M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $21.03 | +2.0% | 421.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |